BA
ABBV icon

Ballast Advisors’s AbbVie ABBV Stock Holding History

Ballast Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
2,140
+1
+0% +$215 0.13% 80
2026
Q1 		$465K Sell
2,139
-23
-1% -$5.1K 0.14% 73
2025
Q4 		$494K Sell
2,162
-116
-5% -$26.4K 0.14% 71
2025
Q3 		$528K Sell
2,278
-149
-6% -$30.3K 0.15% 70
2025
Q2 		$451K Buy
2,427
+69
+3% +$12.8K 0.13% 76
2025
Q1 		$494K Sell
2,358
-316
-12% -$61.4K 0.16% 71
2024
Q4 		$475K Buy
2,674
+137
+5% +$25.2K 0.15% 73
2024
Q3 		$501K Sell
2,537
-184
-7% -$34.3K 0.15% 71
2024
Q2 		$467K Buy
2,721
+171
+7% +$28.3K 0.15% 73
2024
Q1 		$464K Sell
2,550
-169
-6% -$29.1K 0.16% 74
2023
Q4 		$421K Buy
2,719
+2
+0.1% +$292 0.16% 77
2023
Q3 		$405K Sell
2,717
-83
-3% -$12.2K 0.16% 79
2023
Q2 		$377K Sell
2,800
-72
-3% -$10.6K 0.14% 78
2023
Q1 		$458K Buy
2,872
+74
+3% +$11.3K 0.18% 58
2022
Q4 		$452K Sell
2,798
-43
-2% -$6.59K 0.2% 57
2022
Q3 		$381K Sell
2,841
-23
-0.8% -$3.3K 0.18% 62
2022
Q2 		$439K Buy
2,864
+25
+0.9% +$3.82K 0.2% 61
2022
Q1 		$460K Buy
2,839
+1
+0% +$145 0.18% 66
2021
Q4 		$384K Buy
2,838
+1
+0% +$118 0.15% 76
2021
Q3 		$306K Buy
2,837
+2
+0.1% +$229 0.13% 86
2021
Q2 		$319K Sell
2,835
-284
-9% -$32K 0.13% 79
2021
Q1 		$338K Buy
3,119
+191
+7% +$20.4K 0.16% 72
2020
Q4 		$314K Buy
2,928
+2
+0.1% +$192 0.16% 74
2020
Q3 		$256K Buy
2,926
+1
+0% +$94 0.16% 77
2020
Q2 		$287K Buy
+2,925
New +$258K 0.2% 67
2020
Q1 		– Sell
-2,616
Closed -$232K – 155
2019
Q4 		$232K Buy
+2,616
New +$217K 0.17% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ballast Advisors's ABBV Position: Q2 2026 in Review

Ballast Advisors increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $215 and bringing the position to 2,140 shares worth $538K. The position accounts for 0.13% of the portfolio, ranked #80.

Ballast Advisors first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ballast Advisors held 2,140 shares of AbbVie worth $538K as of Q2 2026.
  • Ballast Advisors bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.13% of Ballast Advisors's portfolio in Q2 2026, its #80 holding.
  • Ballast Advisors first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.